navepegritide 5.5 MG Injection

RxCUI: 2739535
RxNorm name: navepegritide 5.5 MG Injection
Display name: navepegritide 5.5 MG Injection
Full name: navepegritide 5.5 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:24

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Yuviwel	NAVEPEGRITIDE	Ascendis Pharma Endocrinology, Inc.	e01c1197-338f-414c-b804-808e129ebc8c	2026-03-25	Warnings, Adverse reactions	Exact identifier rxcui: 2739535

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e01c1197-338f-414c-b804-808e129ebc8c	navepegritide 5.5 MG Injection [PSN] · navepegritide 5.5 MG Injection [SCD]	2	4	These highlights do not include all the information needed to use YUVIWEL safely and effectively. See full prescribing information for YUVIWEL. YUVIWEL ® (navepegritide) for injection, for subcutaneous use Initial U.S. Approval: 2026	20260325